Literature DB >> 15513972

Serum and follicular resistin levels in women with polycystic ovarian syndrome during IVF-stimulated cycles.

Kok-Min Seow1, Chi-Chang Juan, Yung-Pei Hsu, Low-Tone Ho, Yuan-Yung Wang, Jiann-Loung Hwang.   

Abstract

BACKGROUND: Resistin is a hormone linking obesity and insulin resistance. The aim of this study was to compare resistin levels in serum or follicular fluid from women with polycystic ovarian syndrome (PCOS) and controls, both of whom were undergoing IVF.
METHODS: We compared serum and follicular resistin levels in 21 PCOS women and in 18 healthy, normal ovulation, age- and body mass index (BMI)-matched non-PCOS women undergoing IVF. Correlations between serum or follicular fluid resistin levels and reproductive outcome were evaluated.
RESULTS: There was no significant difference in either serum or follicular resistin levels between the control group and the PCOS group as a whole or those with insulin resistance [homeostasis model assessment of insulin resistance index applied to oral glucose tolerance test (HOMA(OGTT)) <4.7]. However, resistin levels in follicular fluid were unexpectedly significantly lower than serum levels (P<0.0001) in both the PCOS and control groups. No significant correlation was found between resistin levels and BMI, estradiol, LH, or fasting or 2 h glucose or insulin levels or between follicular resistin levels and fertilization rate, implantation rate, clinical pregnancy rate, or early miscarriage rate in PCOS.
CONCLUSION: Resistin is unlikely to be a major determining factor in the growth and maturation of oocytes during IVF-stimulated cycles in PCOS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15513972     DOI: 10.1093/humrep/deh589

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  11 in total

1.  Development of a multimarker assay for early detection of ovarian cancer.

Authors:  Zoya Yurkovetsky; Steven Skates; Aleksey Lomakin; Brian Nolen; Trenton Pulsipher; Francesmary Modugno; Jeffrey Marks; Andrew Godwin; Elieser Gorelik; Ian Jacobs; Usha Menon; Karen Lu; Donna Badgwell; Robert C Bast; Anna E Lokshin
Journal:  J Clin Oncol       Date:  2010-04-05       Impact factor: 44.544

2.  Resistin levels of serum and follicular fluid in non-obese patients with polycystic ovary syndrome during IVF cycles.

Authors:  Xiu-E Lu; He-Feng Huang; Mei-Gen Li; Yi-Min Zhu; Yu-Li Qiang; Min-Yue Dong
Journal:  J Zhejiang Univ Sci B       Date:  2005-09       Impact factor: 3.066

3.  E-selectin, resistin and reactive oxygen species levels in GnRH -agonist and -antagonist protocols in IVF/ICSI: a prospective cohort study.

Authors:  Charalampos Siristatidis; Marily Askoxylaki; Christos Varounis; Dimitrios Kassanos; Charalampos Chrelias
Journal:  J Assist Reprod Genet       Date:  2015-05-01       Impact factor: 3.412

Review 4.  Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence.

Authors:  Jie Qiao; Huai L Feng
Journal:  Hum Reprod Update       Date:  2010-07-16       Impact factor: 15.610

5.  Blood Circulating Levels of Adipokines in Polycystic Ovary Syndrome Patients: A Systematic Review and Meta-analysis.

Authors:  Sanaz Mehrabani; Arman Arab; Elham Karimi; Mehran Nouri; Marjan Mansourian
Journal:  Reprod Sci       Date:  2021-09-01       Impact factor: 2.924

6.  Visfatin and resistin serum levels in normal-weight and obese women with polycystic ovary syndrome.

Authors:  Fatemeh Farshchian; Fahimeh Ramezani Tehrani; Houshang Amirrasouli; Hooman Rahimi Pour; Mehdi Hedayati; Faranak Kazerouni; Adeleh Soltani
Journal:  Int J Endocrinol Metab       Date:  2014-07-01

Review 7.  Involvement of Novel Adipokines, Chemerin, Visfatin, Resistin and Apelin in Reproductive Functions in Normal and Pathological Conditions in Humans and Animal Models.

Authors:  Anthony Estienne; Alice Bongrani; Maxime Reverchon; Christelle Ramé; Pierre-Henri Ducluzeau; Pascal Froment; Joëlle Dupont
Journal:  Int J Mol Sci       Date:  2019-09-09       Impact factor: 5.923

8.  Circulating resistin and follistatin levels in obese and non-obese women with polycystic ovary syndrome: A systematic review and meta-analysis.

Authors:  Tahereh Raeisi; Hossein Rezaie; Mina Darand; Akram Taheri; Nazila Garousi; Bahman Razi; Leonardo Roever; Reza Mohseni; Shimels Hussien Mohammed; Shahab Alizadeh
Journal:  PLoS One       Date:  2021-03-19       Impact factor: 3.240

Review 9.  Adipokines and the female reproductive tract.

Authors:  Maxime Reverchon; Christelle Ramé; Michael Bertoldo; Joëlle Dupont
Journal:  Int J Endocrinol       Date:  2014-02-18       Impact factor: 3.257

10.  Ovarian Expression of Adipokines in Polycystic Ovary Syndrome: A Role for Chemerin, Omentin, and Apelin in Follicular Growth Arrest and Ovulatory Dysfunction?

Authors:  Alice Bongrani; Namya Mellouk; Christelle Rame; Marion Cornuau; Fabrice Guérif; Pascal Froment; Joëlle Dupont
Journal:  Int J Mol Sci       Date:  2019-08-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.